HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Comparison of handheld rebound tonometry with Goldmann applanation tonometry in children with glaucoma: a cohort study.

AbstractOBJECTIVE:
To test agreement of two methods to measure intraocular pressure (IOP): rebound tonometry (RBT) and gold standard Goldmann applanation tonometry (GAT) in children with glaucoma.
DESIGN:
Observational prospective cohort study.
SETTING:
Tertiary paediatric glaucoma clinic at a single centre.
PARTICIPANTS:
102 individuals attending a paediatric glaucoma clinic, mean (SD) age 11.85 (3.17), of whom 53 were male.
PRIMARY AND SECONDARY OUTCOME MEASURES:
Intraocular pressure, central corneal thickness, child preference for measurement method.
RESULTS:
Limits of agreement for intraobserver and interobserver were, respectively, (-2.71, 2.98) mm Hg and (-5.75, 5.97) mm Hg. RBT frequently gave higher readings than GAT and the magnitude of disagreement depend on the level of IOP being assessed. Differences of 10 mm Hg were not uncommon. RBT was the preferred method for 70% of children.
CONCLUSIONS:
There is poor agreement between RBT and GAT in children with glaucoma. RBT frequently and significantly overestimates IOP. However, 'normal' RBT readings are likely to be accurate and may spare children an examination under anaesthesia (EUA). High RBT readings should prompt the practitioner to use another standard method of IOP measurement if possible, or consider the RBT measurement in the context of clinical findings before referring the child to a specialist clinic or considering EUA.
AuthorsAnnegret Hella Dahlmann-Noor, Renata Puertas, Shenille Tabasa-Lim, Ahmed El-Karmouty, Mustafa Kadhim, Nicholas Kloster Wride, Amanda Lewis, Dawn Grosvenor, Poornima Rai, Maria Papadopoulos, John Brookes, Catey Bunce, Peng Tee Khaw
JournalBMJ open (BMJ Open) Vol. 3 Issue 4 ( 2013) ISSN: 2044-6055 [Print] England
PMID23550090 (Publication Type: Journal Article)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: